{"data":{"id":4009,"citation":"Fukunaga K, Sakai D, Watanabe K, Nakayama K, Kohara T, Tanaka H, Sunada S, Nabeno M, Okamoto M, Saito K, Eguchi J, Mori A, Tanaka S, Inazawa K, Horikawa T.: Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3\u03b2 inhibitors for Alzheimer's disease. Bioorg Med Chem Lett, Volume 25 (5), 2015","title":"Discovery of novel 2-(alkylmorpholin-4-yl)-6-(3-fluoropyridin-4-yl)-pyrimidin-4(3H)-ones as orally-active GSK-3\u03b2 inhibitors for Alzheimer's disease.","doi":"10.1016\/j.bmcl.2015.01.005","doi_url":"https:\/\/doi.org\/10.1016\/j.bmcl.2015.01.005","pmid":"25655721","pmid_url":"https:\/\/pubmed.ncbi.nlm.nih.gov\/25655721\/","year":2015,"journal":"Bioorg Med Chem Lett","volume":"25","issue":"5","page":"1086-1091","authors":[{"first_name":"Eguchi J","last_name":null,"full_name":null},{"first_name":"Fukunaga K","last_name":null,"full_name":null},{"first_name":"Horikawa T.","last_name":null,"full_name":null},{"first_name":"Inazawa K","last_name":null,"full_name":null},{"first_name":"Kohara T","last_name":null,"full_name":null},{"first_name":"Mori A","last_name":null,"full_name":null},{"first_name":"Nabeno M","last_name":null,"full_name":null},{"first_name":"Nakayama K","last_name":null,"full_name":null},{"first_name":"Okamoto M","last_name":null,"full_name":null},{"first_name":"Saito K","last_name":null,"full_name":null},{"first_name":"Sakai D","last_name":null,"full_name":null},{"first_name":"Sunada S","last_name":null,"full_name":null},{"first_name":"Tanaka H","last_name":null,"full_name":null},{"first_name":"Tanaka S","last_name":null,"full_name":null},{"first_name":"Watanabe K","last_name":null,"full_name":null}],"url":"https:\/\/molmedb.upol.cz\/api\/v1\/publications\/4009","landing_page":"https:\/\/molmedb.upol.cz\/publication\/4009","created_at":"2024-05-21T20:14:34.000000Z","updated_at":null}}